Erin Yeh (Stracuzzi)

Erin Yeh (Stracuzzi) has extensive experience in bioprocess development and purification, highlighted by a current position as Scientist I at MacroGenics, Inc. since August 2015, and previous roles at Teva Pharmaceuticals, where Erin managed teams and led downstream purification processes for fusion proteins and monoclonal antibodies. Throughout a ten-year tenure at Teva, Erin focused on process development, troubleshooting, and tech transfer for clinical GMP manufacture. Prior experience includes positions at Human Genome Sciences and Brown University, where Erin contributed to high-throughput screening and protein purification, respectively. Erin's educational background includes a Master of Science in Health Promotion Management from Marymount University and a Bachelor of Science in Microbiology from the University of Rhode Island.